Mechanisms and current rates of resistance

American Journal of Managed Care

Volumn 4, Issue 10 SUPPL. 2, 1998, Pages

  Doern, Gary V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFACLOR; CEFALEXIN; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFPROZIL; CEFTIBUTEN; CEFUROXIME; CHLORAMPHENICOL; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; CONFERENCE PAPER; CROSS RESISTANCE; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; MORAXELLA CATARRHALIS; OUTPATIENT CARE; PENICILLIN RESISTANCE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT PLANNING;

EID: 0031734007     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Doern GV. Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. Am J Med 1995;99(suppl 6B):6B-3S.
2. Doern GV, Brueggemann AB, Pierce G, Holley, Jr. HP, Rauch A. Antibiotic resistance among clinical isolates of haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study. Antimicrob Agents Chemother 1997;41:292-297.
3. Doern GV, Jones RN, Pfaller MA, Kugler K, and the SENTRY Participants Group. Haemophilus influenzae and moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob Agents Chemother. In press.
4. Wallace, Jr. RJ, Nash DR, Steingrube MS. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis. Am J Med 1990;88:5A-46S.
5. Doern GV, Brueggemann AB, Pierce G, Hogan T, Holley Jr. HP, Rauch A. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: Results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40:2884-2886.
6. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Eighth information supplement, M100-S8. Wayne, PA: National Committee for Clinical Laboratory Standards. 1997.
7. Jacobs MR, Koornhof HJ, Robbins-Browne RM, et al. Emergence of multiply resistant pneumococci. N Engl J Med 1978; 299:735-740.
8. Spika JS, Acklam RR, Plikaytis BD, Oxtoby MJ, the Pneumococcal Surveillance Working Group. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect Dis 1991;163: 1273-1278.
9. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990;34:2075-2080.
10. Thornsberry C, Brown SD, Yee C, Bouchillon SK, Marier JK, Rich T. Increasing penicillin resistance in Streptococcus pneumoniae in the US. Suppl Infect Med 1993; 93:15-24.
11. Doern GV, Brueggeman A, Holley, Jr HP, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996;40:1208-1213.
12. Doern GV, Pfaller MA, Kugler K, Freeman J, Jones RN. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infec Dis. In press.
13. Doern GV, Brueggemann AB, Blocker M, et al. Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States. In press.
14. Laible G, Hakenbeck R. Five independent combinations of mutations can result in low-affinity penicillin-binding protein 2x of Streptococcus pneumoniae. J Bacteriol 1991;173:6986-6990.
15. Markiewica Z, Tomasz A. Variation in penicillin-binding protein patterns of penicillin-resistant clinical isolates of pneumococci. J Clin Microbiol 1989;27:405-410.
16. Jamin M, Hakenbeck R, Frere J-M. Penicillin binding protein 2x as a major contributor to intrinsic β-lactam resistance of Streptococcus pneumoniae. FEBS 1993; 331:101-104.
17. Grebe T, Hakenback R. Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of β-lactam antibiotics. Antimicrob Agents Chemother 1996; 40:829-834.
18. Doern GV, Pfaller MA, Erwin ME, Brueggemann AB, Jones RN. The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada - 1997 Results from the SENTRY antimicrobial surveillance program. In press.
19. Pallares R, Liares J, Vadillo M, et al. Resistance of penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-480.